tiprankstipranks
Trending News
More News >
Beamtree Holdings Ltd (AU:BMT)
ASX:BMT
Australian Market

Beamtree Holdings Ltd (BMT) AI Stock Analysis

Compare
7 Followers

Top Page

AU

Beamtree Holdings Ltd

(Sydney:BMT)

56Neutral
Beamtree Holdings Ltd demonstrates strong revenue growth, but struggles with profitability and cash flow, which weighs heavily on its financial performance score. Technical indicators show a mixed picture with some short-term bullish trends but longer-term resistance. The lack of profitability as seen in the negative P/E ratio is a significant concern for valuation. Without earnings call insights or notable corporate events, these financial and technical factors are the primary drivers of the overall score.

Beamtree Holdings Ltd (BMT) vs. S&P 500 (SPY)

Beamtree Holdings Ltd Business Overview & Revenue Model

Company DescriptionBeamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
How the Company Makes MoneyBeamtree Holdings Ltd generates revenue primarily through the sale of its software solutions and services to healthcare organizations. The company offers subscription-based models for its analytics platforms, which provide ongoing revenue streams. Additionally, Beamtree may engage in licensing agreements for its technology and charge consulting fees for implementing and customizing its systems to fit client needs. The company also benefits from partnerships with healthcare institutions and technology providers, which can result in collaborative projects and shared revenue opportunities.

Beamtree Holdings Ltd Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
27.60M22.77M19.09M8.39M4.12M
Gross Profit
4.89M2.14M2.34M2.77M2.65M
EBIT
-609.00K-7.01M-5.94M-1.03M188.04K
EBITDA
-331.00K-1.24M-2.28M1.02M697.11K
Net Income Common Stockholders
-5.11M-6.91M-4.45M-383.62K382.90K
Balance SheetCash, Cash Equivalents and Short-Term Investments
5.04M8.81M6.35M14.12M4.20M
Total Assets
59.65M62.53M63.91M47.05M32.22M
Total Debt
1.66M755.00K1.12M799.36K44.27K
Net Debt
-3.38M-8.05M-5.23M-13.32M-4.16M
Total Liabilities
12.52M15.31M15.33M4.96M3.01M
Stockholders Equity
47.14M47.22M48.58M42.09M29.22M
Cash FlowFree Cash Flow
-4.51M-1.88M-4.83M-2.64M-26.13K
Operating Cash Flow
-492.00K768.00K-2.32M240.65K1.05M
Investing Cash Flow
-4.02M-2.65M-5.16M-2.98M-849.49K
Financing Cash Flow
749.00K4.34M-286.00K12.65M-128.49K

Beamtree Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.26
Price Trends
50DMA
0.22
Positive
100DMA
0.25
Positive
200DMA
0.26
Negative
Market Momentum
MACD
<0.01
Negative
RSI
61.30
Neutral
STOCH
87.88
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:BMT, the sentiment is Positive. The current price of 0.26 is above the 20-day moving average (MA) of 0.21, above the 50-day MA of 0.22, and below the 200-day MA of 0.26, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.30 is Neutral, neither overbought nor oversold. The STOCH value of 87.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:BMT.

Beamtree Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AURMD
79
Outperform
AU$54.61B27.1425.23%0.85%10.54%38.69%
AURHT
64
Neutral
AU$16.55M140.00-3.11%89.13%69.57%
AUBMT
56
Neutral
AU$72.45M-11.80%14.56%13.36%
52
Neutral
$5.23B3.70-41.86%2.84%16.58%-0.16%
AUPYC
50
Neutral
AU$769.90M-112.97%-84.82%
AUMVF
48
Neutral
AU$321.45M-0.87%6.18%14.24%-109.59%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:BMT
Beamtree Holdings Ltd
0.26
0.04
18.18%
CHEOF
Cochlear
171.24
-38.62
-18.40%
AU:PYC
PYC Therapeutics Limited
1.31
0.36
37.89%
AU:RHT
Resonance Health Ltd
0.04
-0.04
-50.00%
AU:MVF
Monash IVF Group Ltd
0.81
-0.63
-43.75%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
37.67
5.76
18.05%

Beamtree Holdings Ltd Corporate Events

Beamtree Holdings Reports Major Q3 FY25 Progress and Strategic Wins
May 5, 2025

Beamtree Holdings Limited has announced significant progress in its operations for the third quarter of FY25, highlighted by major contract wins and strategic developments. The company has launched the Evolve Collaborative with NHS Confederation in England, renewed a contract in Ireland, and expanded its market presence in Saudi Arabia and the UK. These developments are expected to significantly increase Beamtree’s market share and annual recurring revenue, positioning the company for improved profitability and positive cash generation by the end of FY25.

Beamtree Secures Strategic Contracts for Autonomous Coding Technology
Mar 24, 2025

Beamtree Holdings Limited has announced strategic contract wins for its autonomous coding technology with Barwon Health in Australia, Milton Keynes University NHS Foundation Trust in the UK, and a leading health sciences medical center in Canada. These contracts, while not financially material, signify a strategic milestone for Beamtree, showcasing the demand for its AI technology in key markets and marking the conversion of its sales pipeline as outlined in their first-half reporting.

Beamtree Secures Strategic Contracts for Autonomous Coding
Mar 24, 2025

Beamtree Holdings Limited has secured three new contracts in Australia, the UK, and Canada for its autonomous coding product, valued at approximately $0.6 million annually. These contracts highlight the demand for Beamtree’s AI technology in key markets and mark a strategic achievement that supports the company’s growth and innovation in healthcare data solutions.

Beamtree Strengthens Board with New Appointment Amid Leadership Transition
Mar 9, 2025

Beamtree Holdings Limited has announced the appointment of Professor Andy Hardy to its board of directors, effective 31 March 2025. Professor Hardy, a prominent figure in the healthcare sector, is expected to enhance Beamtree’s strategic direction with his extensive experience in health service leadership and innovation in AI. Concurrently, Professor Mark Britnell will step down from the board to focus on his UK commitments, having significantly contributed to Beamtree’s international success and the development of the Global Impact Committee.

Beamtree Holdings Limited Releases 1H FY25 Results
Feb 18, 2025

Beamtree Holdings Limited has released its 1H FY25 results, providing a general background on the company’s performance. The release emphasizes that the information is for professional analysts and should not be relied upon as investment advice. The company warns against placing undue reliance on forward-looking statements and clarifies that the past performance is illustrative only. The announcement highlights the importance of understanding that many factors, including risks and uncertainties, could cause actual results to differ from those projected.

Beamtree Holdings Reports Robust Growth and Strategic Advances in 1H FY25
Feb 18, 2025

Beamtree Holdings Limited announced continued double-digit revenue growth of 10% for the first half of fiscal year 2025, driven by a 31% increase in international revenue and a high customer renewal rate. The company reported an operating profit, breaking even in cash flow, and securing a new NZ$7.5 million debt facility to support its growth plans. Significant developments include the launch of an Integrated Coding Platform in Saudi Arabia, verbal agreements for new implementations in several countries, and a strong sales pipeline of $61 million. These efforts are expected to accelerate revenue growth and position the company for a cash flow positive status by the end of fiscal year 2025, with a forecast ARR growth target of 20% year on year.

Beamtree Holdings Sees Revenue Growth but Faces Increased Losses
Feb 18, 2025

Beamtree Holdings Limited reported a 10% increase in revenue from ordinary activities, reaching $14,235,000 for the year ended December 31, 2024. Despite the growth in revenue, the company experienced a 12% increase in losses attributable to owners, amounting to $3,246,000, influenced by rising employment costs and other operating expenses.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.